Imaging of the prostate-specific membrane antigen (PSMA) has become an important tool for managing patients with recurrent prostate cancer, and one of the most frequently employed …

Gallium (68 Ga) gozetotide or Gallium (68 Ga) PSMA-11, sold under the brand name Illuccix among others, is a radiopharmaceutical made of 68 Ga conjugated to a inhibitor of the enzyme …

Jul 23, 2021 · This radiopharmaceutical combines the peptidomimetic Glu-NH-CO-NH-Lys (Ahx)-HBED-CC with the radionuclide 68 Ga, enabling specific imaging of tumor cells expressing …

Ga 68 PSMA-11 Injection is indicated for positron emission tomography (PET) of prostate-specific membrane antigen (PSMA) positive lesions in men with prostate cancer: • with suspected...

On 1 December 2020, almost 10 years after its discovery, [68 Ga]Ga-PSMA-11 was approved by the Food and Drug Administration (FDA) [1] as the first 68 Ga-labeled radiopharmaceutical for …

Today, the U.S. Food and Drug Administration approved Gallium 68 PSMA-11 (Ga 68 PSMA-11) – the first drug for positron emission tomography (PET) imaging of prostate-specific membrane...

3 days ago · Objectives. To evaluate the relationship between total lesion PSMA (PSMA TL), serum PSA, histopathological findings and biochemical recurrence (BCR) in patients with …

Feb 6, 2025 · PET and CT imaging studies using 68 Ga-labeled PSMA ligands demonstrated the specific localization of 68 Ga in PC lesions and distant metastatic lesions. [68 Ga]Ga-PSMA …

Apr 8, 2025 · The study utilized 68Ga-PSMA-11 PET imaging to assess outcomes in prostate cancer patients treated with 177Lu-PSMA-617, focusing on whole-body SUVmean as a key …

Jan 17, 2025 · In this prospective study, the clinical utility of [68 Ga]Glu-urea-Lys (Ahx)-HBED-CC (68 Ga-PSMA-11) PET/CT for staging and risk stratification of treatment-naïve PCa was …